Episode 304: A PSMA CD3 Bispecific T-cell Engager in CRPC
Listen now
Description
Tanya Dorff describes acapatamab, a prostate-specific membrane antigen (PSMA) CD3 bispecific engager.
More Episodes
Aditya Bagrodia describes three new drugs/studies in NMIBC.
Published 06/21/24
Silke Gillessen joins Tom and Brian, who give their opinion on the data and new 'Take Home Message' format.
Published 06/10/24
Published 06/10/24
Links
Twitter
Facebook
Instagram
Patreon
Genres
Artwork or description wrong?
Request an update »
Updates may take a few minutes.
Do you host a podcast?
Track your ranks and reviews from Spotify, Apple Podcasts and more.
See hourly chart positions and more than 30 days of history.
Get Chartable Analytics »
See hourly chart positions and more than 30 days of history.
